Settlement of $10 Million reached in W.Va. opioid lawsuit

West Virginia

CHARLESTON, W.Va. (WBOY) – West Virginia Attorney General Patrick Morrisey announced in a release that a $10 million settlement was reached Thursday with a major consulting firm that he stated: “designed marketing plans and programs that helped fuel the state’s opioid epidemic.”
 
The settlement explained allegations that McKinsey & Company Inc. collected millions from the nation’s largest opioid manufacturers, including a more than 15-year relationship with Purdue Pharma, to boost OxyContin sales after the opioid epidemic peaked.
 
The Attorney General alleged that McKinsey targeted high-volume prescribers, considered ways to conceal its activity, and involved itself in conflicts of interest by consulting with governments and nonprofits to clean up the very crisis it helped create, all while still working for those same opioid makers.
 
“Marketing efforts to boost the profits of opioid drugmakers have caused – and continue to cause – immense harm to West Virginia,” Attorney General Morrisey said. “Such strategies valued profits above human life, and those responsible must be held accountable. These funds must be used to solve the root causes of opioid abuse, and I am committed to working to develop a long-term plan to help our state’s citizens and communities on a road to recovery.”
 
The settlement and corresponding lawsuit were filed Thursday in Greenbrier County Circuit Court.
 
According to the release, the settlement requires McKinsey to pay $10 million to the state, prohibits the New York-based company from doing business related to opioids, and requires McKinsey to develop a records retention system. The lawsuit alleged that some employees had considered deleting or destroying documents related to the company’s work with Purdue.
 
According to the Attorney General’s office, McKinsey’s strategy targeted prescribers who wrote the most prescriptions to boost sales and specific patients to increase brand loyalty. For instance, McKinsey allegedly urged Purdue to consider direct-to-patient, mail-order pharmacies after scrutinizing a large pharmacy chain.
 
The Attorney General further alleged that McKinsey “viewed the growing drug abuse crisis as a profit-making opportunity by suggesting Purdue manufacture and market opioid treatment and rescue medications.”

The lawsuit alleges McKinsey also worked with Johnson & Johnson, Mallinckrodt LLC, and Endo Health Solutions Inc., along with Purdue. Attorney General Morrisey filed suit against each of those manufacturers and one other in 2019.
 
The release explained that the settlement does not constitute an admission of wrongdoing by McKinsey. All parties agreed to the settlement to avoid the expense and uncertainty of further litigation, according to officials.

Legal work regarding the McKinsey settlement was handled within the Attorney General’s Office, meaning no portion of the $10 million settlement will be diverted to reimburse outside law firms. That provides substantial savings for state taxpayers and helps ensure proceeds fund the agreement’s intended purpose – remediation of the drug abuse crisis in West Virginia, according to the release.
 
Those wishing to read more about the Attorney General’s lawsuit can do by clicking here.

Copyright 2021 Nexstar Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Link to 12 things you need to know page

WBOY 12 News Facebook Page

Trending Stories